TriLink BioTechnologies

Hot Start dNTPs - A Novel Tool for Controlled Nucleotide Incorporation in PCR

Tony Le, Elena Hidalgo Ashrafi, Sabrina Shore, Victor Timoshchuk, Natasha Paul, Richard Hogrefe, Inna Koukhareva, Alexandre Lebedev, TriLink BioTechnologies

Date Posted: Friday, January 08, 2010

Print Email to a friend

PCR is a widely used scientific tool employed by a variety of applications. Various Hot Start technologies have already been developed using modified PCR components to increase specificity of a reaction. Recently developed CleanAmpTM dNTPs are modified nucleoside triphosphates with a thermolabile 3’-tetrahydrofuranyl protecting group that is released at higher temperatures. These modified dNTPs prevent low temperature primer extension, which can often be a significant problem in PCR. At higher temperatures, the modified dNTPs are deprotected, to allow for incorporation by the DNA polymerase and more specific amplification of the intended target. The use of CleanAmpTM dNTPs provides comparable performance to other Hot Start technologies and shows promise to provide a synergistic effect when used in conjunction with other Hot Start methods. This modified dNTP technology also has the ability to use any DNA polymerase in a Hot Startsystem, which can be very cost effective. Although the utility of CleanAmpTM dNTPs in traditional Hot Start PCR has been previously demonstrated, they can also be used in more advanced PCR applications that require temperature-controlled nucleotide incorporation. In these advanced applications, the CleanAmp TM dNTP modification blocks nucleotide incorporation during initial, lower temperature reactions, allowing for delayed nucleotide activation in a reaction. In summary, CleanAmpTM dNTPs have the potential to provide great versatility and flexibility in a vast number of applications including traditional Hot Start PCR.

Click here to open poster PDF


Comments about this Poster

Click Here to Leave a Comment about this Poster



Related news from our archive

TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites
Glen Research can now sell the patented CleanAmp™ Amidites to third parties for use in production of CleanAmp™ Primers.

TriLink BioTechnologies Announces Supply Agreement with Osmetech Molecular Diagnostics
TriLink to supply reagents for Osmetech's eSensor® cystic fibrosis carrier detection system and the eSensor® XT-8 System for Warfarin sensitivity.

TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems
TriLink to provide Applied Biosystems with custom dye-labeled oligonucleotides which are used as part of the DNA sequencing process.

TriLink Awarded Phase I Grant for a Second Hot Start PCR Project
TriLink Biotechnologies has received a $100,000 Phase I SBIR grant from the National Institutes of Health, to study an approach to PCR activation.